NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

MYO

Myomo Inc

Jun 30 • 04:00PM ET

2.16

Dollar change -0.10
Percentage change -4.42	%

Healthcare • Medical Devices • USA • AMEX

Peers: ZBH INSP TNDM OFIX SRDX RCEL SIBN ATEC BLFS STXS

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.15	Insider Own	8.24%	Shs Outstand	34.44M	Perf Week	-4.85%
Market Cap	77.71M	Forward P/E	98.18	EPS next Y	0.02	Insider Trans	1.65%	Shs Float	33.02M	Perf Month	-29.41%
Enterprise Value	64.46M	PEG	-	EPS next Q	-0.11	Inst Own	52.53%	Short Float	3.15%	Perf Quarter	-55.56%
Income	-5.81M	P/S	2.01	EPS this Y	-28.75%	Inst Trans	11.27%	Short Ratio	1.79	Perf Half Y	-66.36%
Sales	38.63M	P/B	3.43	EPS next Y	110.68%	ROA	-20.26%	Short Interest	1.04M	Perf YTD	-66.46%
Book/sh	0.63	P/C	3.61	EPS next 5Y	-	ROE	-35.68%	52W High	7.17 -69.87%	Perf Year	-28.00%
Cash/sh	0.60	P/FCF	-	EPS past 3/5Y	55.74% 62.04%	ROIC	-19.91%	52W Low	2.16 0.00%	Perf 3Y	24.14%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	32.93% 53.36%	Gross Margin	71.18%	Volatility	6.56% 6.11%	Perf 5Y	-43.46%
Dividend TTM	-	EV/Sales	1.67	EPS Y/Y TTM	45.63%	Oper. Margin	-15.11%	ATR (14)	0.18	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	2.38	Sales Y/Y TTM	97.60%	Profit Margin	-15.05%	RSI (14)	21.71	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	2.66	EPS Q/Q	19.92%	SMA20	-18.81%	Beta	1.41	Target Price	8.70
Payout	-	Debt/Eq	0.38	Sales Q/Q	161.88%	SMA50	-36.66%	Rel Volume	0.77	Prev Close	2.26
Employees	185	LT Debt/Eq	0.35	Earnings	May 07 AMC	SMA200	-53.69%	Avg Volume	579.81K	Price	2.16
IPO	Jun 12, 2017	Option/Short	Yes / Yes	EPS/Sales Surpr.	-5.26% 6.62%	Trades		Volume	445,051	Change	-4.42%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-31-24	Initiated	Craig Hallum	Buy	$7
May-20-24	Initiated	Lake Street	Buy	$7
Dec-15-23	Initiated	H.C. Wainwright	Buy	$6.50
Nov-11-20	Upgrade	ROTH Capital	Neutral → Buy	$5 → $7
May-27-20	Initiated	Dougherty & Company	Buy	$8.50
Oct-02-17	Initiated	H.C. Wainwright	Buy	$12

Jun-25-25 08:56AM	Capricor (CAPR) Moves 20.4% Higher: Will This Strength Last? (Zacks)
Jun-18-25 08:30AM	Myomo Provides Highlights of Todays Investor & Analyst Day Event (Business Wire)
May-08-25 03:31AM	Myomo Inc (MYO) Q1 2025 Earnings Call Highlights: Record Revenue Surge and Strategic Innovations (GuruFocus.com) -30.58%
May-07-25 09:00PM	Myomo outlines 2025 revenue target of $50M-$53M amid advancements in product and marketing strategies (Seeking Alpha)
09:00PM	Myomo, Inc. (MYO) Q1 2025 Earnings Call Transcript (Seeking Alpha)
06:25PM	Loading…
06:25PM	Myomo, Inc. (MYO) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
05:11PM	Myomo Reports First Quarter 2025 Financial and Operating Results (Business Wire)
May-01-25 08:30AM	Myomo to Host Investor & Analyst Day Event on June 18, 2025 (Business Wire)
Apr-30-25 04:05PM	Myomo to Report First Quarter 2025 Financial Results on May 7 (Business Wire)
08:05AM	Myomo Launches the MyoPro® 2x (Business Wire)
Apr-10-25 08:30AM	Myomo Announces Upcoming Changes to its Board of Directors (Business Wire) -8.33%
Apr-09-25 06:03AM	Myomo: Balancing CMS Tailwinds With Long-Term Risks (Seeking Alpha) +5.41%
Mar-31-25 04:05PM	Myomo to Present at the 24th Annual Needham Virtual Healthcare Conference (Business Wire)
Mar-11-25 01:12PM	Q4 2024 Myomo Inc Earnings Call (Thomson Reuters StreetEvents) +40.77%
03:03AM	Myomo Inc (MYO) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Market ... (GuruFocus.com)
05:15PM	Loading…
Mar-10-25 05:15PM	Myomo, Inc. (MYO) Reports Q4 Loss, Tops Revenue Estimates (Zacks) -9.35%
04:05PM	Myomo's Fourth Quarter Financial Results Feature Record Revenue of $12.1 Million (Business Wire)
Mar-07-25 07:06AM	What To Expect From Myomo Inc (MYO) Q4 2024 Earnings (GuruFocus.com)
Mar-03-25 04:05PM	Myomo to Report Fourth Quarter 2024 Financial Results on March 10 (Business Wire) -5.33%
Dec-05-24 07:30AM	Myomo, Inc. Prices $15.0 Million Public Offering of Common Stock (Business Wire) +11.21%
Dec-04-24 04:05PM	Myomo, Inc. Announces Proposed Public Offering of Common Stock (Business Wire)
Nov-07-24 02:22AM	Myomo Inc (MYO) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Initiatives (GuruFocus.com) +20.10%
Nov-06-24 06:00PM	Myomo, Inc. (MYO) Reports Q3 Loss, Tops Revenue Estimates (Zacks) +5.56%
04:05PM	Myomo Reports Record Third Quarter Financial and Operating Results (Business Wire)
Nov-05-24 08:07AM	Myomo Inc (MYO) Q3 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Oct-31-24 04:05PM	Myomo Announces First Private Payer Contracts for MyoPro In-network Coverage (Business Wire) -6.63%
Oct-30-24 04:05PM	Myomo to Report Third Quarter Financial Results on November 6, 2024 (Business Wire)
Oct-18-24 05:01PM	Rosalind Advisors, Inc. Expands Stake in Myomo Inc (GuruFocus.com)
Oct-09-24 05:08PM	Myomo Inc (MYO) Q2 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Expansion ... (GuruFocus.com)
04:05PM	Myomo to Participate in the 2024 Maxim Healthcare Virtual Summit (Business Wire)
08:30AM	Loading…
Sep-12-24 08:30AM	Myomo, Inc. Announces the Launch of Myomo Academy at AOPA National Assembly (Business Wire)
Sep-05-24 04:15PM	Myomo to Participate in Two Investor Conferences in September (Business Wire)
Aug-06-24 04:05PM	Myomo Reports Second Quarter 2024 Financial Results (Business Wire) -13.33%
Jul-30-24 04:05PM	Myomo to Report Second Quarter Financial Results on August 6, 2024 (Business Wire) -5.53% +7.21%
Jul-27-24 07:40AM	The 3 Best Robotic Exoskeleton Stocks to Buy Now (InvestorPlace)
Jul-26-24 06:05PM	Myomo, Inc. (MYO): Hedge Funds Are Bullish on This Robotics Stock Now (Insider Monkey)
Jul-08-24 08:30AM	Myomo Reports Preliminary Second Quarter 2024 Revenues and Operating Metrics (Business Wire) +41.81%
Jun-11-24 10:50AM	Sidoti Events, LLC's Virtual June Small-Cap Conference (ACCESSWIRE) +9.71%
Jun-05-24 05:58PM	Myomo to Present at the Sidoti Virtual Investor Conference on June 12-13, 2024 (Business Wire)
Jun-01-24 02:42AM	Director Thomas Kirk Acquires 50,000 Shares of Myomo Inc (MYO) (GuruFocus.com)
May-17-24 07:01PM	Insider Sale: Chief Medical Officer Harry Kovelman Sells 35,426 Shares of Myomo Inc (MYO) (GuruFocus.com)
May-10-24 04:03PM	Myomo Inc Reports Q1 2024 Earnings: Revenue Up Despite Challenges (GuruFocus.com) +7.58%
01:01PM	Myomo Inc (MYO) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth Amid Financial ... (GuruFocus.com)
May-09-24 01:16PM	Myomo, Inc. (AMEX:MYO) Q1 2024 Earnings Call Transcript (Insider Monkey) -9.41%
May-08-24 04:05PM	Myomo Reports First Quarter 2024 Financial Results (Business Wire) +8.56%
May-06-24 01:19PM	Myomo Receives Reimbursements For MyoPros from CMS (MT Newswires)
08:30AM	Myomo Announces First Lump Sum Reimbursements for MyoPros Delivered to Medicare Part B Beneficiaries Under New CMS Fees (Business Wire)
May-01-24 05:21PM	Myomo to Report First Quarter Financial Results on May 8, 2024 (Business Wire) +7.95% +11.05%
Mar-28-24 04:05PM	Myomo Appoints Heather Getz to its Board of Directors (Business Wire) -6.57% -5.50%
Mar-18-24 11:00AM	Director Thomas Kirk Acquires 50,000 Shares of Myomo Inc (MYO) (GuruFocus.com)
Mar-08-24 10:15AM	Myomo, Inc. (AMEX:MYO) Q4 2023 Earnings Call Transcript (Insider Monkey) -9.38%
Mar-07-24 06:00PM	Myomo, Inc. (MYO) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Myomo Reports Fourth Quarter and Full Year 2023 Financial Results (Business Wire)
Mar-01-24 08:00AM	CMS Posts Final Medicare DMEPOS Fee Schedule Rate for the MyoPro® (Business Wire) +31.05%
Feb-29-24 04:05PM	Myomo to Report Fourth Quarter Financial Results on March 7, 2024 (Business Wire)
Jan-19-24 04:05PM	Myomo Announces Closing of $6 Million Registered Direct Offering of Common Stock Priced At-the-Market (Business Wire) -6.33%
Jan-17-24 08:05AM	Myomo Announces $6 Million Registered Direct Offering of Common Stock Priced At-the-Market (Business Wire) +7.89%
08:00AM	Myomo Reports Preliminary Fourth Quarter Revenue and Backlog (Business Wire)
Dec-20-23 08:50AM	What Makes Myomo, Inc. (MYO) a Good Fit for 'Trend Investing' (Zacks) -19.21%
Dec-12-23 07:00AM	7 Stock Winners That Are Up 1,000% or More in 2023 (InvestorPlace)
Dec-01-23 10:00AM	Top Penny Stocks for Q4 2023 (Investopedia) +7.42%
Nov-20-23 04:16PM	3 Hot Penny Stocks to Buy in Q4 for Promising Potential (InvestorPlace) +5.88%
Nov-08-23 11:47AM	Myomo, Inc. (AMEX:MYO) Q3 2023 Earnings Call Transcript (Insider Monkey) +7.39%
Nov-07-23 04:05PM	Myomo Reports Third Quarter 2023 Financial Results Featuring Record Product Revenue and Authorizations (Business Wire) +6.02%
Nov-06-23 08:30AM	CMS Posts Proposed Medicare DMEPOS Fee Schedule Rate for the MyoPro® for Review at the Upcoming HCPCS Public Meeting (Business Wire) +21.17%
Nov-02-23 10:08AM	Myomo Announces that CMS has Classified the MyoPro Orthosis Under the Brace Benefit Category (Business Wire) +8.00%
Oct-31-23 04:05PM	Myomo to Report Third Quarter Financial Results on November 7, 2023 (Business Wire) +10.62%
Aug-29-23 04:05PM	Myomo Announces Closing of $4.4 Million Public Offering (Business Wire) -6.09%
Aug-28-23 12:38PM	Is Myomo (MYO) a Hidden Gem or a Value Trap? A Comprehensive Analysis (GuruFocus.com) +18.69%
Aug-25-23 07:00AM	Myomo Announces Pricing of $4.4 Million Public Offering (Business Wire) -10.13%
Aug-24-23 07:33PM	Myomo Inc (MYO): A Hidden Gem or a Potential Value Trap? (GuruFocus.com) +18.82%
04:15PM	Myomo, Inc. Announces Proposed Public Offering (Business Wire)
04:05PM	Myomo Receives Medicare Part B Reimbursement for First MyoPro® Claims (Business Wire)
Aug-21-23 04:05PM	Myomo Announces Two German Social Court Rulings Ordering MyoPro® Reimbursement (Business Wire) +10.80% -6.91%
Aug-09-23 05:30PM	Myomo, Inc. (MYO) Reports Q2 Loss, Tops Revenue Estimates (Zacks) +8.00% -7.67%
04:05PM	Myomo Reports Second Quarter 2023 Financial Results Featuring Year Over Year Growth in Revenue and Operating Metrics (Business Wire)
Aug-02-23 04:05PM	Myomo to Report Second Quarter Financial Results on August 9, 2023 (Business Wire) -7.02%
Jul-05-23 10:50AM	Myomo's (MYO) MyoPro Seeks CMS Classification for Medicare Cover (Zacks)
Jul-03-23 08:30AM	Centers for Medicare and Medicaid Services Accepts Myomos Application to Classify the MyoPro® as a Brace (Business Wire) +19.31%
Jun-14-23 04:05PM	Myomo To Participate in the Maxim Group Virtual Healthcare Conference Hosted by M-Vest (Business Wire) +6.27%
May-22-23 09:55AM	Here's Why Myomo, Inc. (MYO) Is a Great 'Buy the Bottom' Stock Now (Zacks)
May-10-23 06:05PM	Myomo, Inc. (MYO) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
May-09-23 07:05PM	Supernus Pharmaceuticals (SUPN) Q1 Earnings and Revenues Beat Estimates (Zacks)
May-05-23 07:45AM	Owens & Minor (OMI) Beats Q1 Earnings and Revenue Estimates (Zacks)
May-03-23 04:05PM	Myomo to Report First Quarter Financial Results on May 10, 2023 (Business Wire) -7.69%
Apr-10-23 08:30AM	Myomo Receives Technology License Fee Payment from China Joint Venture Company (Business Wire) +5.22%
Mar-16-23 05:30AM	SVB Collapse Spurs Finance Executives to Re-Evaluate Cash Strategies (The Wall Street Journal)
Mar-15-23 08:30AM	Myomo Makes NYSE American Section 610(b) Public Announcement (Business Wire)
Mar-14-23 11:11AM	Myomo, Inc. (AMEX:MYO) Q4 2022 Earnings Call Transcript (Insider Monkey) -6.84%
Mar-13-23 09:45AM	Myomo, Inc. (MYO) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
08:30AM	Myomo Reports Fourth Quarter and Full Year 2022 Financial Results (Business Wire)
Mar-07-23 10:12AM	Myomo to Report Fourth Quarter Financial Results on March 13, 2023 (Business Wire)
Mar-06-23 04:05PM	Myomo To Participate in the 35th Annual Roth Conference (Business Wire) +11.26%
Feb-06-23 04:05PM	MyoPro Approved in Australia by National Disability Insurance Scheme (Business Wire)
Feb-01-23 04:25PM	7 Top Short-Squeeze Candidates to Watch in February (InvestorPlace)
Jan-30-23 04:05PM	Myomo Appoints Yitzchak Jacobovitz to its Board of Directors (Business Wire)
Jan-17-23 04:05PM	Myomo Announces Closing of $6.5 Million Upsized Public Offering (Business Wire)
Jan-12-23 08:30AM	Myomo Announces Pricing of $6.5 Million Upsized Public Offering (Business Wire) -14.99%
Jan-10-23 04:17PM	Myomo Announces Initiative to Reduce Cash Burn (Business Wire) -8.79%
Dec-07-22 05:00PM	Myomo Provides Update on Progress to Obtain Medicare Part B Reimbursement for MyoPro (Business Wire) -8.28%

Myomo, Inc. is a wearable medical robotics company, which engages in the business of developing, designing, and producing myoelectric orthotics for people with neuromuscular disorders. The firm is also involved in selling products through various other sales channels including through orthotics and prosthetics providers, veterans' administration, and to distributors in certain accounts and geographic markets. The company was founded by Stephen Kelly, John McBean, Mira Sahney, and Kailas N. Narendran on September 1, 2004 and is headquartered in Burlington, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
David Henry	Officer	Jun 30 '25	Proposed Sale	2.19	23,587	51,656		Jun 30 08:12 PM
Harry Kovelman	Officer	Jun 28 '25	Proposed Sale	2.19	13,054	28,588		Jun 30 08:04 PM
Harry Kovelman	Officer	Jun 06 '25	Proposed Sale	2.97	5,743	17,057		Jun 06 07:08 PM
David Henry	Officer	Jun 06 '25	Proposed Sale	2.97	8,373	24,868		Jun 06 06:50 PM
KIRK THOMAS F	Director	May 15 '25	Buy	3.25	36,824	119,678	344,700	May 15 04:53 PM
KIRK THOMAS F	Director	May 14 '25	Buy	3.25	1,943	6,315	307,876	May 15 04:53 PM
GUDONIS PAUL R	Chief Executive Officer	May 15 '25	Buy	3.22	30,000	96,612	1,051,671	May 15 04:36 PM
KIRK THOMAS F	Director	May 12 '25	Buy	3.35	50,000	167,500	305,933	May 14 08:27 AM
KIRK THOMAS F	Director	Mar 13 '25	Buy	5.00	7,400	37,000	255,933	Mar 14 09:00 PM
Mitchell Micah	Chief Commercial Officer	Mar 14 '25	Sale	5.16	48,000	247,565	140,572	Mar 14 05:36 PM
MICAH MITCHELL	Officer	Mar 14 '25	Proposed Sale	5.16	48,000	247,565		Mar 14 05:24 PM
Kovelman Harry	Chief Medical Officer	Mar 12 '25	Sale	5.50	30,000	165,018	97,973	Mar 13 04:41 PM
Micah Mitchell	Officer	Mar 13 '25	Proposed Sale	5.22	1,283	6,697		Mar 13 04:31 PM
David Henry	Officer	Mar 13 '25	Proposed Sale	5.22	2,019	10,539		Mar 13 04:30 PM
Harry Kovelman	Officer	Mar 13 '25	Proposed Sale	5.22	1,496	7,809		Mar 13 04:28 PM
HARRY KOVELMAN	Officer	Mar 12 '25	Proposed Sale	5.50	30,000	165,015		Mar 12 04:59 PM
GUDONIS PAUL R	Chief Executive Officer	Feb 13 '25	Option Exercise	0.05	694	33	1,014,963	Feb 18 04:33 PM
Harry Kovelman	Officer	Nov 04 '24	Proposed Sale	3.70	121	448		Nov 04 03:19 PM
Harry Kovelman	Officer	Oct 03 '24	Proposed Sale	3.86	121	467		Oct 03 12:54 PM
Kovelman Harry	Chief Medical Officer	Sep 05 '24	Sale	3.76	6,700	25,183	123,556	Sep 09 04:04 PM
Kovelman Harry	Chief Medical Officer	Sep 03 '24	Sale	4.01	2,029	8,140	130,395	Sep 05 08:27 AM
Harry Kovelman	Officer	Sep 04 '24	Proposed Sale	3.89	139	541		Sep 04 06:26 PM
Harry Kovelman	Officer	Sep 03 '24	Proposed Sale	4.00	18,500	74,000		Sep 03 05:55 PM
Harry Kovelman	Officer	Aug 05 '24	Proposed Sale	3.96	128	507		Aug 05 11:53 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MYO

Myomo Inc

Upgrade your FINVIZ experience